Table 2. Adverse events.
| Studies | CRC patients | Evaluated patients | Total PIPAC-OX | CTCAE | |||
|---|---|---|---|---|---|---|---|
| 1–2 | 3 | 4 | 5 | ||||
| Siebert [2019] (13) | 2 | 2 | 5 | ns | ns | 2 | ns |
| Katdare [2019] (14) | 3 | 3 | 3 | 1 | 0 | 0 | 0 |
| Demtröder [2016] (15) | 17 | 17 | 42 | 25 | 4 | 0 | 0 |
| Somashekhar [2019] (16) | 1 | 1 | 3 | 0 | 0 | 0 | 0 |
CRC, colorectal cancer; PIPAC-OX, pressurized intraperitoneal aerosol chemotherapy with oxaliplatin; CTCAE, Common Terminology Criteria for Adverse Events; ns, not shown.